APO Research
Talk to an analyst

APO RESEARCH · REPORT

Eyedrops

Compare research editions
View pricing & licenses

Selected research

Industry Research

Eyedrops Industry Research Report 2026

26 December 2025142 pages

Choose your research edition.

Industry ResearchEyedrops Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Eyedrops Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Eyedrops Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Eyedrops Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Eyedrops Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Eyedrops market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Eyedrops is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Eyedrops is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Eyedrops is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Eyedrops include Akorn, Alcon, Allergan, Bausch + Lomb, Clear Eyes, Harrow Health, Novax Pharma, OmniVision Pharma and Prestige Consumer Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Eyedrops market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Eyedrops Market by Company

Akorn

Alcon

Allergan

Bausch + Lomb

Clear Eyes

Harrow Health

Novax Pharma

OmniVision Pharma

Prestige Consumer Healthcare

Qianliming

Renhe

Rohto Pharmaceutical

RUIZHU

Sager Pharma

Similasan

The United Laboratories

Thea pharmaceuticals

TheraTears

URSAPHARM

Bayer

Santen Pharmaceutical

Novartis

Johnson & Johnson

Abbott

Eyedrops Segment by Type

Health Care Eyedrops

Hormonal Eyedrops

Antibiotics Eyedrops

Eyedrops Segment by Application

Eye Disease

Eye Care

Others

Eyedrops Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Eyedrops market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Eyedrops and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Eyedrops.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Eyedrops manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Eyedrops by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Eyedrops in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Eyedrops Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Eyedrops Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Eyedrops Sales Market Share by Manufacturers (2021-2026) Table 8. Global Eyedrops Revenue of Manufacturers (2021-2026) Table 9. Global Eyedrops Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Eyedrops Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Eyedrops Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Eyedrops, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Eyedrops, Product Type & Application Table 14. Global Eyedrops Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Eyedrops by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Akorn Company Information Table 19. Akorn Business Overview Table 20. Akorn Eyedrops Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Akorn Eyedrops Product Portfolio Table 22. Akorn Recent Developments Table 23. Alcon Company Information Table 24. Alcon Business Overview Table 25. Alcon Eyedrops Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Alcon Eyedrops Product Portfolio Table 27. Alcon Recent Developments Table 28. Allergan Company Information Table 29. Allergan Business Overview Table 30. Allergan Eyedrops Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Allergan Eyedrops Product Portfolio Table 32. Allergan Recent Developments Table 33. Bausch + Lomb Company Information Table 34. Bausch + Lomb Business Overview Table 35. Bausch + Lomb Eyedrops Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Bausch + Lomb Eyedrops Product Portfolio Table 37. Bausch + Lomb Recent Developments Table 38. Clear Eyes Company Information Table 39. Clear Eyes Business Overview Table 40. Clear Eyes Eyedrops Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Clear Eyes Eyedrops Product Portfolio Table 42. Clear Eyes Recent Developments Table 43. Harrow Health Company Information Table 44. Harrow Health Business Overview Table 45. Harrow Health Eyedrops Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Harrow Health Eyedrops Product Portfolio Table 47. Harrow Health Recent Developments Table 48. Novax Pharma Company Information Table 49. Novax Pharma Business Overview Table 50. Novax Pharma Eyedrops Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Novax Pharma Eyedrops Product Portfolio Table 52. Novax Pharma Recent Developments Table 53. OmniVision Pharma Company Information Table 54. OmniVision Pharma Business Overview Table 55. OmniVision Pharma Eyedrops Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. OmniVision Pharma Eyedrops Product Portfolio Table 57. OmniVision Pharma Recent Developments Table 58. Prestige Consumer Healthcare Company Information Table 59. Prestige Consumer Healthcare Business Overview Table 60. Prestige Consumer Healthcare Eyedrops Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Prestige Consumer Healthcare Eyedrops Product Portfolio Table 62. Prestige Consumer Healthcare Recent Developments Table 63. Qianliming Company Information Table 64. Qianliming Business Overview Table 65. Qianliming Eyedrops Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Qianliming Eyedrops Product Portfolio Table 67. Qianliming Recent Developments Table 68. Renhe Company Information Table 69. Renhe Business Overview Table 70. Renhe Eyedrops Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Renhe Eyedrops Product Portfolio Table 72. Renhe Recent Developments Table 73. Rohto Pharmaceutical Company Information Table 74. Rohto Pharmaceutical Business Overview Table 75. Rohto Pharmaceutical Eyedrops Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Rohto Pharmaceutical Eyedrops Product Portfolio Table 77. Rohto Pharmaceutical Recent Developments Table 78. RUIZHU Company Information Table 79. RUIZHU Business Overview Table 80. RUIZHU Eyedrops Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. RUIZHU Eyedrops Product Portfolio Table 82. RUIZHU Recent Developments Table 83. Sager Pharma Company Information Table 84. Sager Pharma Business Overview Table 85. Sager Pharma Eyedrops Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Sager Pharma Eyedrops Product Portfolio Table 87. Sager Pharma Recent Developments Table 88. Similasan Company Information Table 89. Similasan Business Overview Table 90. Similasan Eyedrops Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Similasan Eyedrops Product Portfolio Table 92. Similasan Recent Developments Table 93. The United Laboratories Company Information Table 94. The United Laboratories Business Overview Table 95. The United Laboratories Eyedrops Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. The United Laboratories Eyedrops Product Portfolio Table 97. The United Laboratories Recent Developments Table 98. Thea pharmaceuticals Company Information Table 99. Thea pharmaceuticals Business Overview Table 100. Thea pharmaceuticals Eyedrops Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Thea pharmaceuticals Eyedrops Product Portfolio Table 102. Thea pharmaceuticals Recent Developments Table 103. TheraTears Company Information Table 104. TheraTears Business Overview Table 105. TheraTears Eyedrops Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. TheraTears Eyedrops Product Portfolio Table 107. TheraTears Recent Developments Table 108. URSAPHARM Company Information Table 109. URSAPHARM Business Overview Table 110. URSAPHARM Eyedrops Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. URSAPHARM Eyedrops Product Portfolio Table 112. URSAPHARM Recent Developments Table 113. Bayer Company Information Table 114. Bayer Business Overview Table 115. Bayer Eyedrops Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Bayer Eyedrops Product Portfolio Table 117. Bayer Recent Developments Table 118. Santen Pharmaceutical Company Information Table 119. Santen Pharmaceutical Business Overview Table 120. Santen Pharmaceutical Eyedrops Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Santen Pharmaceutical Eyedrops Product Portfolio Table 122. Santen Pharmaceutical Recent Developments Table 123. Novartis Company Information Table 124. Novartis Business Overview Table 125. Novartis Eyedrops Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Novartis Eyedrops Product Portfolio Table 127. Novartis Recent Developments Table 128. Johnson & Johnson Company Information Table 129. Johnson & Johnson Business Overview Table 130. Johnson & Johnson Eyedrops Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Johnson & Johnson Eyedrops Product Portfolio Table 132. Johnson & Johnson Recent Developments Table 133. Abbott Company Information Table 134. Abbott Business Overview Table 135. Abbott Eyedrops Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Abbott Eyedrops Product Portfolio Table 137. Abbott Recent Developments Table 138. Global Eyedrops Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 139. Global Eyedrops Sales by Region (2021-2026) & (K Units) Table 140. Global Eyedrops Sales Market Share by Region (2021-2026) Table 141. Global Eyedrops Sales by Region (2027-2032) & (K Units) Table 142. Global Eyedrops Sales Market Share by Region (2027-2032) Table 143. Global Eyedrops Revenue by Region (2021-2026) & (US$ Million) Table 144. Global Eyedrops Revenue Market Share by Region (2021-2026) Table 145. Global Eyedrops Revenue by Region (2027-2032) & (US$ Million) Table 146. Global Eyedrops Revenue Market Share by Region (2027-2032) Table 147. North America Eyedrops Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. North America Eyedrops Sales by Country (2021-2026) & (K Units) Table 149. North America Eyedrops Sales by Country (2027-2032) & (K Units) Table 150. North America Eyedrops Revenue by Country (2021-2026) & (US$ Million) Table 151. North America Eyedrops Revenue by Country (2027-2032) & (US$ Million) Table 152. Europe Eyedrops Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Europe Eyedrops Sales by Country (2021-2026) & (K Units) Table 154. Europe Eyedrops Sales by Country (2027-2032) & (K Units) Table 155. Europe Eyedrops Revenue by Country (2021-2026) & (US$ Million) Table 156. Europe Eyedrops Revenue by Country (2027-2032) & (US$ Million) Table 157. Asia Pacific Eyedrops Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. Asia Pacific Eyedrops Sales by Country (2021-2026) & (K Units) Table 159. Asia Pacific Eyedrops Sales by Country (2027-2032) & (K Units) Table 160. Asia Pacific Eyedrops Revenue by Country (2021-2026) & (US$ Million) Table 161. Asia Pacific Eyedrops Revenue by Country (2027-2032) & (US$ Million) Table 162. South America Eyedrops Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. South America Eyedrops Sales by Country (2021-2026) & (K Units) Table 164. South America Eyedrops Sales by Country (2027-2032) & (K Units) Table 165. South America Eyedrops Revenue by Country (2021-2026) & (US$ Million) Table 166. South America Eyedrops Revenue by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Eyedrops Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 168. Middle East and Africa Eyedrops Sales by Country (2021-2026) & (K Units) Table 169. Middle East and Africa Eyedrops Sales by Country (2027-2032) & (K Units) Table 170. Middle East and Africa Eyedrops Revenue by Country (2021-2026) & (US$ Million) Table 171. Middle East and Africa Eyedrops Revenue by Country (2027-2032) & (US$ Million) Table 172. Global Eyedrops Sales by Type (2021-2026) & (K Units) Table 173. Global Eyedrops Sales by Type (2027-2032) & (K Units) Table 174. Global Eyedrops Sales Market Share by Type (2021-2026) Table 175. Global Eyedrops Sales Market Share by Type (2027-2032) Table 176. Global Eyedrops Revenue by Type (2021-2026) & (US$ Million) Table 177. Global Eyedrops Revenue by Type (2027-2032) & (US$ Million) Table 178. Global Eyedrops Revenue Market Share by Type (2021-2026) Table 179. Global Eyedrops Revenue Market Share by Type (2027-2032) Table 180. Global Eyedrops Price by Type (2021-2026) & (US$/Unit) Table 181. Global Eyedrops Price by Type (2027-2032) & (US$/Unit) Table 182. Global Eyedrops Sales by Application (2021-2026) & (K Units) Table 183. Global Eyedrops Sales by Application (2027-2032) & (K Units) Table 184. Global Eyedrops Sales Market Share by Application (2021-2026) Table 185. Global Eyedrops Sales Market Share by Application (2027-2032) Table 186. Global Eyedrops Revenue by Application (2021-2026) & (US$ Million) Table 187. Global Eyedrops Revenue by Application (2027-2032) & (US$ Million) Table 188. Global Eyedrops Revenue Market Share by Application (2021-2026) Table 189. Global Eyedrops Revenue Market Share by Application (2027-2032) Table 190. Global Eyedrops Price by Application (2021-2026) & (US$/Unit) Table 191. Global Eyedrops Price by Application (2027-2032) & (US$/Unit) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Eyedrops Distributors List Table 195. Eyedrops Customers List Table 196. Eyedrops Industry Trends Table 197. Eyedrops Industry Drivers Table 198. Eyedrops Industry Restraints Table 199. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Eyedrops Product Image Figure 5. Global Eyedrops Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Eyedrops Market Size (2021-2032) & (US$ Million) Figure 7. Global Eyedrops Sales (2021-2032) & (K Units) Figure 8. Global Eyedrops Average Price (US$/Unit) & (2021-2032) Figure 9. Health Care Eyedrops Product Image Figure 10. Hormonal Eyedrops Product Image Figure 11. Antibiotics Eyedrops Product Image Figure 12. Eye Disease Product Image Figure 13. Eye Care Product Image Figure 14. Others Product Image Figure 15. Global Eyedrops Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Eyedrops, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Eyedrops Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Eyedrops Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Eyedrops Sales by Region in 2025 Figure 21. Global Eyedrops Revenue by Region in 2025 Figure 22. North America Eyedrops Market Size by Country in 2025 Figure 23. North America Eyedrops Sales Market Share by Country (2021-2032) Figure 24. North America Eyedrops Revenue Market Share by Country (2021-2032) Figure 25. United States Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Eyedrops Market Size by Country in 2025 Figure 29. Europe Eyedrops Sales Market Share by Country (2021-2032) Figure 30. Europe Eyedrops Revenue Market Share by Country (2021-2032) Figure 31. Germany Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Eyedrops Market Size by Country in 2025 Figure 42. Asia Pacific Eyedrops Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Eyedrops Revenue Market Share by Country (2021-2032) Figure 44. China Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Eyedrops Market Size by Country in 2025 Figure 53. South America Eyedrops Sales Market Share by Country (2021-2032) Figure 54. South America Eyedrops Revenue Market Share by Country (2021-2032) Figure 55. Brazil Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Eyedrops Market Size by Country in 2025 Figure 59. Middle East and Africa Eyedrops Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Eyedrops Revenue Market Share by Country (2021-2032) Figure 61. Egypt Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Eyedrops Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Eyedrops Sales Market Share by Type (2021-2032) Figure 67. Global Eyedrops Revenue Market Share by Type (2021-2032) Figure 68. Global Eyedrops Price (US$/Unit) by Type (2021-2032) Figure 69. Global Eyedrops Sales Market Share by Application (2021-2032) Figure 70. Global Eyedrops Revenue Market Share by Application (2021-2032) Figure 71. Global Eyedrops Price (US$/Unit) by Application (2021-2032) Figure 72. Eyedrops Value Chain Figure 73. Eyedrops Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Eyedrops Industry Opportunities and Challenges

Scope & coverage.

Types
  • Health Care Eyedrops
  • Hormonal Eyedrops
  • Antibiotics Eyedrops
Applications
  • Eye Disease
  • Eye Care
  • Others
Companies covered
  • Akorn
  • Alcon
  • Allergan
  • Bausch + Lomb
  • Clear Eyes
  • Harrow Health
  • Novax Pharma
  • OmniVision Pharma
  • Prestige Consumer Healthcare
  • Qianliming
  • Renhe
  • Rohto Pharmaceutical
  • RUIZHU
  • Sager Pharma
  • Similasan
  • The United Laboratories
  • Thea pharmaceuticals
  • TheraTears
  • URSAPHARM
  • Bayer
  • Santen Pharmaceutical
  • Novartis
  • Johnson & Johnson
  • Abbott

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Eyedrops Market Size (2021-2032)
  4. 2.2.2 Global Eyedrops Sales (2021-2032)
  5. 2.2.3 Global Eyedrops Market Average Price (2021-2032)
  6. 2.3 Eyedrops by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Health Care Eyedrops
  9. 2.3.3 Hormonal Eyedrops
  10. 2.3.4 Antibiotics Eyedrops
  11. 2.4 Eyedrops by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Eye Disease
  14. 2.4.3 Eye Care
  15. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Eyedrops Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Eyedrops Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Eyedrops Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Eyedrops Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Eyedrops Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Eyedrops, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Eyedrops, Product Type & Application
  8. 3.8 Global Manufacturers of Eyedrops, Established Date
  9. 3.9 Global Eyedrops Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Akorn
  2. 4.1.1 Akorn Company Information
  3. 4.1.2 Akorn Business Overview
  4. 4.1.3 Akorn Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Akorn Eyedrops Product Portfolio
  6. 4.1.5 Akorn Recent Developments
  7. 4.2 Alcon
  8. 4.2.1 Alcon Company Information
  9. 4.2.2 Alcon Business Overview
  10. 4.2.3 Alcon Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Alcon Eyedrops Product Portfolio
  12. 4.2.5 Alcon Recent Developments
  13. 4.3 Allergan
  14. 4.3.1 Allergan Company Information
  15. 4.3.2 Allergan Business Overview
  16. 4.3.3 Allergan Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Allergan Eyedrops Product Portfolio
  18. 4.3.5 Allergan Recent Developments
  19. 4.4 Bausch + Lomb
  20. 4.4.1 Bausch + Lomb Company Information
  21. 4.4.2 Bausch + Lomb Business Overview
  22. 4.4.3 Bausch + Lomb Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Bausch + Lomb Eyedrops Product Portfolio
  24. 4.4.5 Bausch + Lomb Recent Developments
  25. 4.5 Clear Eyes
  26. 4.5.1 Clear Eyes Company Information
  27. 4.5.2 Clear Eyes Business Overview
  28. 4.5.3 Clear Eyes Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Clear Eyes Eyedrops Product Portfolio
  30. 4.5.5 Clear Eyes Recent Developments
  31. 4.6 Harrow Health
  32. 4.6.1 Harrow Health Company Information
  33. 4.6.2 Harrow Health Business Overview
  34. 4.6.3 Harrow Health Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Harrow Health Eyedrops Product Portfolio
  36. 4.6.5 Harrow Health Recent Developments
  37. 4.7 Novax Pharma
  38. 4.7.1 Novax Pharma Company Information
  39. 4.7.2 Novax Pharma Business Overview
  40. 4.7.3 Novax Pharma Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Novax Pharma Eyedrops Product Portfolio
  42. 4.7.5 Novax Pharma Recent Developments
  43. 4.8 OmniVision Pharma
  44. 4.8.1 OmniVision Pharma Company Information
  45. 4.8.2 OmniVision Pharma Business Overview
  46. 4.8.3 OmniVision Pharma Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 OmniVision Pharma Eyedrops Product Portfolio
  48. 4.8.5 OmniVision Pharma Recent Developments
  49. 4.9 Prestige Consumer Healthcare
  50. 4.9.1 Prestige Consumer Healthcare Company Information
  51. 4.9.2 Prestige Consumer Healthcare Business Overview
  52. 4.9.3 Prestige Consumer Healthcare Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Prestige Consumer Healthcare Eyedrops Product Portfolio
  54. 4.9.5 Prestige Consumer Healthcare Recent Developments
  55. 4.10 Qianliming
  56. 4.10.1 Qianliming Company Information
  57. 4.10.2 Qianliming Business Overview
  58. 4.10.3 Qianliming Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Qianliming Eyedrops Product Portfolio
  60. 4.10.5 Qianliming Recent Developments
  61. 4.11 Renhe
  62. 4.11.1 Renhe Company Information
  63. 4.11.2 Renhe Business Overview
  64. 4.11.3 Renhe Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Renhe Eyedrops Product Portfolio
  66. 4.11.5 Renhe Recent Developments
  67. 4.12 Rohto Pharmaceutical
  68. 4.12.1 Rohto Pharmaceutical Company Information
  69. 4.12.2 Rohto Pharmaceutical Business Overview
  70. 4.12.3 Rohto Pharmaceutical Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Rohto Pharmaceutical Eyedrops Product Portfolio
  72. 4.12.5 Rohto Pharmaceutical Recent Developments
  73. 4.13 RUIZHU
  74. 4.13.1 RUIZHU Company Information
  75. 4.13.2 RUIZHU Business Overview
  76. 4.13.3 RUIZHU Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 RUIZHU Eyedrops Product Portfolio
  78. 4.13.5 RUIZHU Recent Developments
  79. 4.14 Sager Pharma
  80. 4.14.1 Sager Pharma Company Information
  81. 4.14.2 Sager Pharma Business Overview
  82. 4.14.3 Sager Pharma Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Sager Pharma Eyedrops Product Portfolio
  84. 4.14.5 Sager Pharma Recent Developments
  85. 4.15 Similasan
  86. 4.15.1 Similasan Company Information
  87. 4.15.2 Similasan Business Overview
  88. 4.15.3 Similasan Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Similasan Eyedrops Product Portfolio
  90. 4.15.5 Similasan Recent Developments
  91. 4.16 The United Laboratories
  92. 4.16.1 The United Laboratories Company Information
  93. 4.16.2 The United Laboratories Business Overview
  94. 4.16.3 The United Laboratories Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 The United Laboratories Eyedrops Product Portfolio
  96. 4.16.5 The United Laboratories Recent Developments
  97. 4.17 Thea pharmaceuticals
  98. 4.17.1 Thea pharmaceuticals Company Information
  99. 4.17.2 Thea pharmaceuticals Business Overview
  100. 4.17.3 Thea pharmaceuticals Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Thea pharmaceuticals Eyedrops Product Portfolio
  102. 4.17.5 Thea pharmaceuticals Recent Developments
  103. 4.18 TheraTears
  104. 4.18.1 TheraTears Company Information
  105. 4.18.2 TheraTears Business Overview
  106. 4.18.3 TheraTears Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 TheraTears Eyedrops Product Portfolio
  108. 4.18.5 TheraTears Recent Developments
  109. 4.19 URSAPHARM
  110. 4.19.1 URSAPHARM Company Information
  111. 4.19.2 URSAPHARM Business Overview
  112. 4.19.3 URSAPHARM Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 URSAPHARM Eyedrops Product Portfolio
  114. 4.19.5 URSAPHARM Recent Developments
  115. 4.20 Bayer
  116. 4.20.1 Bayer Company Information
  117. 4.20.2 Bayer Business Overview
  118. 4.20.3 Bayer Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Bayer Eyedrops Product Portfolio
  120. 4.20.5 Bayer Recent Developments
  121. 4.21 Santen Pharmaceutical
  122. 4.21.1 Santen Pharmaceutical Company Information
  123. 4.21.2 Santen Pharmaceutical Business Overview
  124. 4.21.3 Santen Pharmaceutical Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Santen Pharmaceutical Eyedrops Product Portfolio
  126. 4.21.5 Santen Pharmaceutical Recent Developments
  127. 4.22 Novartis
  128. 4.22.1 Novartis Company Information
  129. 4.22.2 Novartis Business Overview
  130. 4.22.3 Novartis Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Novartis Eyedrops Product Portfolio
  132. 4.22.5 Novartis Recent Developments
  133. 4.23 Johnson & Johnson
  134. 4.23.1 Johnson & Johnson Company Information
  135. 4.23.2 Johnson & Johnson Business Overview
  136. 4.23.3 Johnson & Johnson Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Johnson & Johnson Eyedrops Product Portfolio
  138. 4.23.5 Johnson & Johnson Recent Developments
  139. 4.24 Abbott
  140. 4.24.1 Abbott Company Information
  141. 4.24.2 Abbott Business Overview
  142. 4.24.3 Abbott Eyedrops Sales, Revenue and Gross Margin (2021-2026)
  143. 4.24.4 Abbott Eyedrops Product Portfolio
  144. 4.24.5 Abbott Recent Developments
5 Global Eyedrops Market Scenario by Region
  1. 5.1 Global Eyedrops Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Eyedrops Sales by Region: 2021-2032
  3. 5.2.1 Global Eyedrops Sales by Region: 2021-2026
  4. 5.2.2 Global Eyedrops Sales by Region: 2027-2032
  5. 5.3 Global Eyedrops Revenue by Region: 2021-2032
  6. 5.3.1 Global Eyedrops Revenue by Region: 2021-2026
  7. 5.3.2 Global Eyedrops Revenue by Region: 2027-2032
  8. 5.4 North America Eyedrops Market Facts & Figures by Country
  9. 5.4.1 North America Eyedrops Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Eyedrops Sales by Country (2021-2032)
  11. 5.4.3 North America Eyedrops Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Eyedrops Market Facts & Figures by Country
  16. 5.5.1 Europe Eyedrops Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Eyedrops Sales by Country (2021-2032)
  18. 5.5.3 Europe Eyedrops Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Eyedrops Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Eyedrops Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Eyedrops Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Eyedrops Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Eyedrops Market Facts & Figures by Country
  41. 5.7.1 South America Eyedrops Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Eyedrops Sales by Country (2021-2032)
  43. 5.7.3 South America Eyedrops Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Eyedrops Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Eyedrops Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Eyedrops Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Eyedrops Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Eyedrops Sales by Type (2021-2032)
  2. 6.1.1 Global Eyedrops Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Eyedrops Sales Market Share by Type (2021-2032)
  4. 6.2 Global Eyedrops Revenue by Type (2021-2032)
  5. 6.2.1 Global Eyedrops Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Eyedrops Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Eyedrops Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Eyedrops Sales by Application (2021-2032)
  2. 7.1.1 Global Eyedrops Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Eyedrops Sales Market Share by Application (2021-2032)
  4. 7.2 Global Eyedrops Revenue by Application (2021-2032)
  5. 7.2.1 Global Eyedrops Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Eyedrops Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Eyedrops Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Eyedrops Value Chain Analysis
  2. 8.1.1 Eyedrops Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Eyedrops Production Mode & Process
  5. 8.2 Eyedrops Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Eyedrops Distributors
  8. 8.2.3 Eyedrops Customers
9 Global Eyedrops Analyzing Market Dynamics
  1. 9.1 Eyedrops Industry Trends
  2. 9.2 Eyedrops Industry Drivers
  3. 9.3 Eyedrops Industry Opportunities and Challenges
  4. 9.4 Eyedrops Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst